Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Oracle Slips on Report It Wants to Buy Medical-Records Firm Cerner

Published 12/17/2021, 06:55 AM
Updated 12/17/2021, 06:57 AM
© Reuters.

© Reuters.

By Dhirendra Tripathi

Investing.com – Oracle stock (NYSE:ORCL) traded 4% lower in Friday’s premarket on reports of the company pursuing its biggest acquisition yet to push deeper into healthcare.

According to The Wall Street Journal, the enterprise software company could pay as much as $30 billion to buy Cerner (NASDAQ:CERN), an electronic-medical-records company that had revenue of $4.3 billion in the nine months ending September 30 and a market value of nearly $24 billion as of Thursday. Cerner stock soared 19% premarket.

Healthcare already has a key presence in Oracle’s current revenue stream. The company offering technology to help insurers, care providers and public health systems parse data for better patient outcomes.

The acquisition is expected to help Oracle’s pivot to the Cloud, a move the company was initially relatively slow to embrace. Its strategy has become more aggressive in the last year.  

In a post-Covid world, healthcare has become a go-to industry for tech companies to tap new areas of growth. Microsoft (NASDAQ:MSFT) itself has struck a $16-billion deal to buy Nuance Communications (NASDAQ:NUAN), a provider of clinical speech recognition software, medical transcription and medical imaging. That deal awaits regulatory approval.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.